Skip to page body Patient Care Survivorship Research Cancer Types News Giving Community Partners Clinical Trials
UCLA's Jonsson Comprehensive Cancer Center
Take the Jonsson Cancer Center Site Survey

JCCC Member Directory

David W. Gjertson, Ph.D.
David W. Gjertson, Ph.D.

Affiliation(s):

Adjunct Professor, Department of Biostatistics, Department of Pathology
Member, JCCC Tumor Immunology Program Area

Contact Information:

Phone:
(310) 206-0255
Email:

Scientific Interest(s):

Dr. David Gjertson’s research is focused on statistical issues related to two main topics: organ transplantation and DNA identification. In the transplantation arena, he has assisted in the investigation of novel organ allocation schemes which promise equitable allocation of scarce compatible kidneys even for small pools and for minority patients. His research has also centered on elucidating (via standard and Bayesian methodologies) the factors most strongly influencing long-term graft survival and predicting chronic organ failure. With regard to DNA identification, he has been able to follow-up his thesis research (concerning proper statistical interpretation of evidence) through collaboration with Long Beach Genetics, Inc., a genetic testing laboratory. Generally, his work involves deriving likelihoods of pedigrees based on DNA profiles with special problematic circumstances like mutation, population substructure or relatives as possible suspects.

Selected Cancer-Related Publications:

Chodon T, Comin-Anduix B, Chmielowski B, Koya RC, Wu Z, Auerbach M, Ng C, Avramis E, Seja E, Villanueva A, McCannel TA, Ishiyama A, Czernin J, Radu CG, Wang X, Gjertson DW, Cochran AJ, Cornetta K, Wong DJ, Kaplan-Lefko P, Hamid O, Samlowski W, Cohen PA, Daniels GA, Mukherji B, Yang L, Zack JA, Kohn DB, Heath JR, Glaspy JA, Witte ON, Baltimore D, Economou JS, Ribas A. Adoptive transfer of MART-1 T-cell receptor transgenic lymphocytes and dendritic cell vaccination in patients with metastatic melanoma. Clin Cancer Res. 2014 May 1;20(9):2457-65. doi: 10.1158/1078-0432.CCR-13-3017. Epub 2014 Mar 14.

Kim SG, Veena MS, Basak SK, Han E, Tajima T, Gjertson DW, Starr J, Eidelman O, Pollard HB, Srivastava M, Srivatsan ES, Wang MB. Curcumin treatment suppresses IKKBeta kinase activity of salivary cells of patients with head and neck cancer: a pilot study. Clin Cancer Res. 2011 Sep 15;17(18):5953-61. doi: 10.1158/1078-0432.CCR-11-1272. Epub 2011 Aug 5.

Kim HG, Tashkin DP, Clements PJ, Li G, Brown MS, Elashoff R, Gjertson DW, Abtin F, Lynch DA, Strollo DC, Goldin JG. A computer-aided diagnosis system for quantitative scoring of extent of lung fibrosis in scleroderma patients. Clin Exp Rheumatol. 2010 Sep-Oct;28(5 Suppl 62):S26-35. Epub 2010 Nov 3.

Tsai EW, Wallace WD, Gjertson DW, Reed EF, Ettenger RB. Significance of intragraft CD138+ lymphocytes and p-S6RP in pediatric kidney transplant biopsies. Transplantation. 2010 Oct 27;90(8):875-81. doi: 10.1097/TP.0b013e3181f24e3c.

Bonagura VR, Du Z, Ashouri E, Luo L, Hatam LJ, DeVoti JA, Rosenthal DW, Steinberg BM, Abramson AL, Gjertson DW, Reed EF, Rajalingam R. Activating killer cell immunoglobulin-like receptors 3DS1 and 2DS1 protect against developing the severe form of recurrent respiratory papillomatosis. Hum Immunol. 2010 Feb;71(2):212-9. doi: 10.1016/j.humimm.2009.10.009. Epub 2009 Oct 25.